Clinical trial
Race-related Alternative Splicing: Novel Targets in Prostate Cancer
NCT03424213 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Race-related Alternative Splicing: Novel Targets in Prostate Cancer
- Lead sponsor
- Duke University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 30, 2018
- Completion date
- July 14, 2021
- Enrollment
- 169 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer